Laugesen C, Ranjan AG, Schmidt S, Norgaard K, et al. Low-Dose Dasiglucagon Versus Oral Glucose for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes: A Phase 2, Randomized, Three-Arm Crossover Study. Diabetes Care 2022 Apr 27. pii: 145035. doi: 10.2337/dc21-2304.
PMID: 35475907